[
    [
        {
            "time": "2023-10-05",
            "original_text": "沃森生物：公司13价肺炎结合疫苗国际注册和出口的各项工作正在按计划持续推进中",
            "features": {
                "keywords": [
                    "沃森生物",
                    "13价肺炎结合疫苗",
                    "国际注册",
                    "出口",
                    "持续推进"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司13价肺炎结合疫苗国际注册和出口的各项工作正在按计划持续推进中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "沃森生物：公司二价HPV疫苗申报生产的相关工作在按程序持续推进中，目前正处于审评阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "二价HPV疫苗",
                    "申报生产",
                    "持续推进",
                    "审评阶段"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司二价HPV疫苗申报生产的相关工作在按程序持续推进中，目前正处于审评阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "沃森生物：截至目前，公司新冠mRNA疫苗处于Ⅲ期临床研究阶段，重组新型冠状病毒疫苗（黑猩猩腺病毒载体）处于Ⅱ期临床研究阶段，重组新型冠状病毒疫苗（CHO细胞）处于Ⅱ期临床研究阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "新冠mRNA疫苗",
                    "Ⅲ期临床",
                    "重组新型冠状病毒疫苗",
                    "黑猩猩腺病毒载体",
                    "CHO细胞",
                    "Ⅱ期临床"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：截至目前，公司新冠mRNA疫苗处于Ⅲ期临床研究阶段，重组新型冠状病毒疫苗（黑猩猩腺病毒载体）处于Ⅱ期临床研究阶段，重组新型冠状病毒疫苗（CHO细胞）处于Ⅱ期临床研究阶段",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "沃森生物：子公司上海泽润研发的九价HPV疫苗已经在开展三期临床研究的前期准备工作",
            "features": {
                "keywords": [
                    "沃森生物",
                    "上海泽润",
                    "九价HPV疫苗",
                    "三期临床",
                    "前期准备"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：子公司上海泽润研发的九价HPV疫苗已经在开展三期临床研究的前期准备工作",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "北向资金疯狂抢筹大消费板块，五粮液创历史最大净买入",
            "features": {
                "keywords": [
                    "北向资金",
                    "大消费板块",
                    "五粮液",
                    "净买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金疯狂抢筹大消费板块，五粮液创历史最大净买入",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-23",
            "original_text": "A股融资融券日报：两融余额增加70.33亿元（9月23日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "增加"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加70.33亿元（9月23日）",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        }
    ]
]